Table 4.

Alosetron Versus Traditional IBS-D Treatments: Healthcare Utilization^*

Resource Use	Alosetron Mean ± SE (range)	Traditional Therapy Mean ± SE (range)	P Value
All Physician Visits	3.8 ±0.1 (0-43)	4.5 ± 0.3 (0-61)	.032
IBS-Related Visits	0.7 ±0.0	1.1 ±0.1 (0-27)	.0006
All Medications	9.2 ±0.2 (0-68)	9.5 ± 0.6 (0-60)	0.638
IBS Prescriptions per Week	1.0 ±0.1 (0-14)	0.9 ± 0.1 (0-8)	.644
IBS Over-the-Counter Agents per Week	0.3 ±0.0 (0-4)	0.7 ±0.1 (0-21)	<.001

^*Results were similar for patients with restriction of daily activities, who used slightly more resources overall.

IBS, irritable bowel syndrome; IBS-D, irritable bowel syndrome-diarrhea; SE, standard error.

Adapted from Chey WD et al. DDW abstract Tul386. Gastroenterology. 2013;76(6).²